Related Experiment Video
Updated: Nov 2, 2025

09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
905
Eradicating micrometastases with immune checkpoint blockade: Strike while the iron is hot
Yelena Y Janjigian1, Jedd D Wolchok2, Charlotte E Ariyan3
1Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
Cancer Cell
|June 15, 2021
Abstract:
Immune checkpoint blockade (ICB) is transforming treatment for many cancers. While ICB alone initially demonstrated efficacy in patients with metastatic melanoma, it has expanded to other types and to earlier-stage cancers. We describe ICB history, mechanisms underlying variation in response, and how ICB is being integrated into adjuvant and neoadjuvant treatment approaches.

